StockData

Jyong Biotech Ltd. (MENS) shareholders

MENSNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 0/30
$1.86+0.06 (+3.33%)

Close on Nov 18, 2026Market cap $141.41MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.6%
0M of 76M shares
Institutional holders
19
5 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Perfect Minds Co., Ltd
Joint filing with Innovation Global Group Limited (33.34%), Unity Trust Limited as trustee of The Innovation Trust (33.34%) and 1 more
25,349,50033.34%13D (active)Jun 16, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MENSValueChange% of portfolio
BlackRock, Inc.260,3170.34%$538.86K+1,5570.00%
Geode Capital Management, LLC68,8820.09%$142.59K+4,6500.00%
Hrt Financial LP50,4230.07%$104.00K+38,6560.00%
XTX Topco Ltd29,0660.04%$60.17KNew0.00%
Renaissance Technologies LLC22,9000.03%$47.40KNew0.00%
China Universal Asset Management Co., Ltd.12,1000.02%$25.05K−1,0730.00%
State of Wyoming11,2080.01%$23.20KNew0.00%
Morgan Stanley6,1120.01%$12.65K−1890.00%
Barclays PLC5,9310.01%$12.28K+7420.00%
JPMorgan Chase & Co5,3790.01%$11.83K−3000.00%
UBS Group AG4,0460.01%$8.38K−33,3170.00%
Mirae Asset Global Investments Co., Ltd.3,4000.00%$7.04K−4720.00%
Bnp Paribas Arbitrage, Snc2,7100.00%$5.61K+8290.00%
Citigroup Inc2,5010.00%$5.18K−2860.00%
Gf Fund Management Co. Ltd.1,5590.00%$3.23K−1180.00%
Tower Research Capital LLC (TRC)1,0700.00%$2.22K−10,6330.00%
Cornerstone Financial Management LLC2340.00%$484New0.00%
Bell Investment Advisors, Inc2060.00%$427−2670.00%
Caitong International Asset Management Co., Ltd90.00%$19New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026190M0.6%5 / 59 / 30M0M
Q1 2026170M0.6%4 / 67 / 60M0M
Q4 2025191M0.9%13 / 51 / 21M0M
Q3 202580M0.1%6 / 02 / 00M0M
Q2 202520M0.1%2 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Fu-Feng KuoCEO, Director, 10% owner25,349,50033.34%Apr 8, 2026
Wei (Vivi) ZhangCFO––Apr 14, 2026
Ming Tsan HsuDirector3,0000.00%Apr 1, 2026
Hung-Shu FanDirector––Apr 1, 2026
Feng-Lin HsuDirector3,0000.00%Apr 1, 2026
Pang-Chieh ChiDirector––Apr 1, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.40%
0M shares short
Days to cover
5.1
At 0M shares a day
Change since last report
-5.4%
From 0M shares
Short volume, 20 days
52.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Jyong Biotech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 9,198 shares on Oct 6, 2026 over the last 90 days.

See a number that looks wrong?